利爾化學(002258.SZ)擬與科迪華上海共設子公司
格隆匯1月13日丨利爾化學(002258.SZ)公佈,公司於2020年1月13日與科迪華農業科技(上海)有限公司(“科迪華上海”)簽訂了《股東協議》,共同出資設立子公司,註冊資本:人民幣5.5億元,其中,公司出資4.4億元,佔比80%。
此次合資設立子公司,將深化雙方公司的合作,有利於公司擴大經營規模,增強公司產品的市場競爭力及綜合實力。此次投資合作將充分發揮合資各方在資源、市場、技術、生產等方面的優勢,符合公司經營發展戰略。同時,此次投資額度佔公司淨資產比例不高,不會對公司財務經營狀況產生較大不利影響,不存在損害公司及全體股東尤其是中小股東利益的情形,待合資公司項目投產後,將會對公司未來財務狀況、經營成果產生一定積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.